NEW YORK New York – William Meyers, a resident of Stamford, will be among those honored at the Israel Cancer Research Fund (ICRF) Ribbons of Hope Virtual Gala on Tuesday, August 10, at 7:45 p.m. Actor Richard Kind will serve as the evening’s master of ceremonies.

Meyers, who has served for more than six years as a member of the ICRF Connecticut Chapter Board, is a 12-year survivor of glioblastoma – one of the most aggressive and deadliest forms of brain cancer. According to Meyers’ neurooncologist at Memorial Sloan Kettering Cancer Center, he is his longest living patient with a glioblastoma. 

After receiving this devastating diagnosis in 2009, Meyers, who was then just 41 years old, underwent a craniotomy, radiation and 18 months of chemotherapy. Incredibly, he was able to continue to work for five years before leaving his 25-year career in equity research at several firms, including Lehman Brothers and Barclays. He holds a BA from Brandeis University and both an MA and MBA from New York University Stern School of Business. 

In addition to his leadership on behalf of ICRF, Meyers has served on the Board of Congregation Agudath Sholom in Stamford, CT, where he is currently a member of the Finance Committee. 

Meyers first learned of ICRF many years before his own personal battle, after his 28- year- old cousin, Ira Sohn z”l, tragically passed away from cancer in 1993, leaving behind a wife and six- month- old daughter. The experience inspired him to become a dedicated supporter of ICRF’s mission for over two decades prior to his own diagnosis and his decision to join the chapter’s leadership in 2015. 

Meyers and his wife Kori are the parents of Devorah (and Michael), Sam (and Emma), and Ben.

The Israel Cancer Research Fund (ICRF) was founded in 1975 by a group of North American physicians, scientists and lay leaders who sought to ensure adequate funding for high-potential cancer research investigations. ICRF grants are selected after an intensive peer review by a Scientific Review Panel (SRP) composed of leading North American physicians and scientists. With the 2020-2021 grants, ICRF funding has now surpassed 2,500 grants totaling more than $77.7 million. Israeli cancer researchers have contributed to some of the most significant cancer breakthroughs of recent years and have resulted in collaborations with major international cancer organizations. In addition to Connecticut, ICRF has chapters in Toronto, Montreal, New York, Los Angeles, Palm Springs/Coachella Valley, Chicago, and Jerusalem. 

For more information about the gala, visit icrfonline.org/gala2021/.